Purified EPA versus combined EPA/DHA in coronary heart disease: clinical outcomes, mechanisms, safety, and functional food perspectives
Prescription omega-3 fatty acids have been widely investigated as adjunctive therapies for reducing residual cardiovascular risk in patients with coronary heart disease (CHD). Although purified eicosapentaenoic acid (EPA) and combined eicosapentaenoic acid/docosahexaenoic acid (EPA/DHA) formulations both lower triglyce...